These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 1469467)
1. Metabolic changes of glioma following chemotherapy: an experimental study using four PET tracers. Sato K; Kameyama M; Ishiwata K; Katakura R; Yoshimoto T J Neurooncol; 1992 Sep; 14(1):81-9. PubMed ID: 1469467 [TBL] [Abstract][Full Text] [Related]
2. Tumor diagnosis by PET: potential of seven tracers examined in five experimental tumors including an artificial metastasis model. Ishiwata K; Takahashi T; Iwata R; Tomura M; Tada M; Itoh J; Kameyama M; Ido T Int J Rad Appl Instrum B; 1992 Aug; 19(6):611-8. PubMed ID: 1387872 [TBL] [Abstract][Full Text] [Related]
3. Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine. Reinhardt MJ; Kubota K; Yamada S; Iwata R; Yaegashi H J Nucl Med; 1997 Feb; 38(2):280-7. PubMed ID: 9025756 [TBL] [Abstract][Full Text] [Related]
4. Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine, L-[methyl-14C]methionine, [6-3H]thymidine, and gallium-67. Kubota K; Ishiwata K; Kubota R; Yamada S; Tada M; Sato T; Ido T J Nucl Med; 1991 Nov; 32(11):2118-23. PubMed ID: 1834814 [TBL] [Abstract][Full Text] [Related]
5. Clinical application of 18F-FUdR in glioma patients--PET study of nucleic acid metabolism. Kameyama M; Ishiwata K; Tsurumi Y; Itoh J; Sato K; Katakura R; Yoshimoto T; Hatazawa J; Ito M; Ido T J Neurooncol; 1995; 23(1):53-61. PubMed ID: 7623069 [TBL] [Abstract][Full Text] [Related]
6. O-[18F]fluoromethyl-L-tyrosine is a potential tracer for monitoring tumour response to chemotherapy using PET: an initial comparative in vivo study with deoxyglucose and thymidine. Yamaura G; Yoshioka T; Fukuda H; Yamaguchi K; Suzuki M; Furumoto S; Iwata R; Ishioka C Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1134-9. PubMed ID: 16779557 [TBL] [Abstract][Full Text] [Related]
7. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy. Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Dethy S; Brotchi J; Hildebrand J J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808 [TBL] [Abstract][Full Text] [Related]
8. Modulation of BUdR labeling index in rat brain tumors following intracarotid ACNU administration. Mineura K; Watanabe K; Izumi I; Kowada M J Neurooncol; 1992 Nov; 14(3):201-5. PubMed ID: 1460484 [TBL] [Abstract][Full Text] [Related]
9. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine. Kaschten B; Stevenaert A; Sadzot B; Deprez M; Degueldre C; Del Fiore G; Luxen A; Reznik M J Nucl Med; 1998 May; 39(5):778-85. PubMed ID: 9591574 [TBL] [Abstract][Full Text] [Related]
10. Acquisition of resistance to antitumor alkylating agent ACNU: a possible target of positron emission tomography monitoring. Kawai H; Toyohara J; Kado H; Nakagawa T; Takamatsu S; Furukawa T; Yonekura Y; Kubota T; Fujibayashi Y Nucl Med Biol; 2006 Jan; 33(1):29-35. PubMed ID: 16459256 [TBL] [Abstract][Full Text] [Related]
11. PET 2-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with gemcitabine. Haberkorn U; Bellemann ME; Altmann A; Gerlach L; Morr I; Oberdorfer F; Brix G; Doll J; Blatter J; van Kaick G J Nucl Med; 1997 Aug; 38(8):1215-21. PubMed ID: 9255154 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of 4'-[methyl-14C]thiothymidine for in vivo DNA synthesis imaging. Toyohara J; Kumata K; Fukushi K; Irie T; Suzuki K J Nucl Med; 2006 Oct; 47(10):1717-22. PubMed ID: 17015909 [TBL] [Abstract][Full Text] [Related]
13. Feasibility of fluorine-18-fluorophenylalanine for tumor imaging compared with carbon-11-L-methionine. Kubota K; Ishiwata K; Kubota R; Yamada S; Takahashi J; Abe Y; Fukuda H; Ido T J Nucl Med; 1996 Feb; 37(2):320-5. PubMed ID: 8667070 [TBL] [Abstract][Full Text] [Related]
14. Tumor cell spheroids as a model for evaluation of metabolic changes after irradiation. Senekowitsch-Schmidtke R; Matzen K; Truckenbrodt R; Mattes J; Heiss P; Schwaiger M J Nucl Med; 1998 Oct; 39(10):1762-8. PubMed ID: 9776284 [TBL] [Abstract][Full Text] [Related]
15. A comparative study on protein incorporation of L-[methyl-3H]methionine, L-[1-14C]leucine and L-2-[18F]fluorotyrosine in tumor bearing mice. Ishiwata K; Kubota K; Murakami M; Kubota R; Senda M Nucl Med Biol; 1993 Nov; 20(8):895-9. PubMed ID: 8298568 [TBL] [Abstract][Full Text] [Related]
17. Trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid (anti-18F-FACBC) is a feasible alternative to 11C-methyl-L-methionine and magnetic resonance imaging for monitoring treatment response in gliomas. Sasajima T; Ono T; Shimada N; Doi Y; Oka S; Kanagawa M; Baden A; Mizoi K Nucl Med Biol; 2013 Aug; 40(6):808-15. PubMed ID: 23701701 [TBL] [Abstract][Full Text] [Related]
18. Comparison of iodotyrosines and methionine uptake in a rat glioma model. Langen KJ; Clauss RP; Holschbach M; Mühlensiepen H; Kiwit JC; Zilles K; Coenen HH; Müller-Gärtner HW J Nucl Med; 1998 Sep; 39(9):1596-9. PubMed ID: 9744350 [TBL] [Abstract][Full Text] [Related]
19. Effect of corticosteroid on protein and nucleic acid synthesis in human glial tumor cells. Chen TT; Mealey J Cancer Res; 1973 Jul; 33(7):1721-3. PubMed ID: 4721230 [No Abstract] [Full Text] [Related]
20. [Radiochemotherapy-related changes in the brain parenchyma of glioma patients evaluated repeatedly by C15O2, C15O, 15O2, and 18F-fluorodeoxyglucose (FDG) PET]. Mineura K; Suda Y; Sasajima T; Kowada M; Ogawa T; Shishido F; Uemura K No Shinkei Geka; 1989 Oct; 17(10):945-52. PubMed ID: 2510045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]